Jonathan Yong
Stock Analyst at UBS
(3.15)
# 1,203
Out of 4,761 analysts
110
Total ratings
57.89%
Success rate
9.54%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Initiates: Neutral | $5.5 | $10.05 | -45.27% | 4 | Dec 4, 2024 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $4.40 | -9.09% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $14.82 | +55.20% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $18.61 | +34.34% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $10.16 | +195.28% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $8.14 | +47.42% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.81 | +66.32% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $18.10 | +43.65% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $49.28 | -71.59% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $77.24 | +24.29% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $17.68 | +81.00% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $27.58 | +280.71% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $97.53 | -17.97% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $249.85 | -7.54% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $90.44 | +11.68% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $11.51 | +134.58% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $6.93 | +116.45% | 5 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $38 | $31.07 | +22.30% | 2 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $127.06 | -21.30% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $597.71 | -24.71% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.92 | +143.90% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $11.74 | +496.25% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $10.55 | +61.14% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $283.81 | +23.32% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $39.65 | +139.60% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $17.94 | -52.62% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $24.52 | +67.21% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $6.22 | +173.31% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.51 | +142.17% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $78.91 | +7.72% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $172.24 | -15.23% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $57.68 | +83.77% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $180.03 | -12.79% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $299.81 | +22.74% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $255.91 | +148.13% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $63.48 | +84.31% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $15.61 | +92.18% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $316.42 | -5.82% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $129.60 | -26.70% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $466.42 | +6.13% | 1 | Oct 15, 2021 |
eHealth
Dec 4, 2024
Initiates: Neutral
Price Target: $5.5
Current: $10.05
Upside: -45.27%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $4.40
Upside: -9.09%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $14.82
Upside: +55.20%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $18.61
Upside: +34.34%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $10.16
Upside: +195.28%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $8.14
Upside: +47.42%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.81
Upside: +66.32%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $18.10
Upside: +43.65%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $49.28
Upside: -71.59%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $77.24
Upside: +24.29%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $17.68
Upside: +81.00%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $27.58
Upside: +280.71%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $97.53
Upside: -17.97%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $249.85
Upside: -7.54%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $90.44
Upside: +11.68%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $11.51
Upside: +134.58%
Jun 30, 2023
Maintains: Neutral
Price Target: $13 → $15
Current: $6.93
Upside: +116.45%
Jun 22, 2023
Maintains: Outperform
Price Target: $35 → $38
Current: $31.07
Upside: +22.30%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $127.06
Upside: -21.30%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $597.71
Upside: -24.71%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.92
Upside: +143.90%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $11.74
Upside: +496.25%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $10.55
Upside: +61.14%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $283.81
Upside: +23.32%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $39.65
Upside: +139.60%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $17.94
Upside: -52.62%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $24.52
Upside: +67.21%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $6.22
Upside: +173.31%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.51
Upside: +142.17%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $78.91
Upside: +7.72%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $172.24
Upside: -15.23%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $57.68
Upside: +83.77%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $180.03
Upside: -12.79%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $299.81
Upside: +22.74%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $255.91
Upside: +148.13%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $63.48
Upside: +84.31%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $15.61
Upside: +92.18%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $316.42
Upside: -5.82%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $129.60
Upside: -26.70%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $466.42
Upside: +6.13%